Annual Report • Apr 30, 2025
Annual Report
Open in ViewerOpens in native device viewer
| 2024 | 2023 | |
|---|---|---|
| € | € | |
| Assets | ||
| Property, plant and equipment | 3.836.743 | 3.829.978 |
| Intangible assets | 3.763.300 | 3.682.866 |
| Conventional assets | 302.300 | - |
| Total non-current assets | 7.902.343 | 7.512.844 |
| Conventional assets | 588.363 | 371.411 |
| Trade and other receivables | 1.431.322 | 1.554.417 |
| Cash and cash equivalents | 209.792 | 98.080 |
| Assets classified as held for sale | 432.721 | 411.791 |
| Total current assets | 2.662.198 | 2.435.699 |
| Total assets | 10.564.541 | 9.948.543 |
| Equity | ||
| Share capital | 2.820.547 | 2.820.547 |
| Share premium reserve | 1.282.911 | 1.282.911 |
| Reserves | 1.109.587 | 359.210 |
| Total equity | 5.213.045 | 4.462.668 |
| Liabilities | ||
| Loans and financing | 1.542.693 | 1.820.630 |
| Deferred tax liabilities | 167.450 | 172.256 |
| Deferred income | 42.578 | 47.309 |
| Total non-current liabilities | 1.752.721 | 2.040.195 |
| Bank overdrafts | 1.194.497 | 1.207.976 |
| Current portion of long-term loans | 356.348 | 354.450 |
| Trade and other liabilities | 1.960.898 | 1.827.427 |
| Deferred income | 4.731 | 4.731 |
| Tax liabilities | 32.540 | 22.440 |
| Liabilities classified as held for sale | 49.761 | 28.656 |
| Total current liabilities | 3.598.775 | 3.445.680 |
| Total liabilities | 5.351.496 | 5.485.875 |
| Total equity and liabilities | 10.564.541 | 9.948.543 |
| 2024 | 2023 | |
|---|---|---|
| € | € | |
| Income | 6.938.549 | 5.866.676 |
| Cost of sales | (3.260.811) | (2.697.059) |
| Gross profit | 3.677.738 | 3.169.617 |
| Other operating income | 31.932 | 80.458 |
| Distribution and selling expenses | (85.329) | (97.915) |
| Administrative expenses | (2.386.401 | (2.220.450) |
| Impairment in trade receivables and conventional assets | (48.540) | (35.803) |
| Operating profit | 1.189.400 | 895.907 |
| Financing income - total |
5.473 | 511 |
| Financing costs - total |
(186.646) | (185.504) |
| Net financing costs | (181.173) | (184.993) |
| Profit before taxation |
1.008.227 | 710.914 |
| Taxation | (243.456) | (164.905) |
| Profit for the year | 764.771 | 546.009 |
| Other comprehensive income | ||
| Amounts not to be reclassified in profit and loss in subsequent periods: |
||
| Taxation in other comprehensive income | 3.945 | 3.945 |
| Amounts which will or may be reclassified in profit and loss in | ||
| subsequent periods: | ||
| Exchange difference created from the translation and | ||
| consolidation of the financial statements of companies abroad | 3.439 | (70.547) |
| Other comprehensive income/(expenses) for the year |
7.384 | (66.602) |
| Comprehensive income for the year |
772.155 | 479.407 |
| Basic profit per share (cents) |
5.97 | 4.26 |
| Fully diluted per share (cents) |
5.97 | 4.26 |
| 2024 | 2023 | |
|---|---|---|
| € | € | |
| Cash flow from operations | ||
| Profit for the year | 764.771 | 546.009 |
| Adjustments for: | ||
| Depreciation of property, plant and equipment | 237.778 | 198.569 |
| Depreciation of computer programmes | 1.511 | 463 |
| Depreciation of research and development | 306.365 | 381.973 |
| Profit from sale of property, plant and equipment |
(5.963) | (6.247) |
| Reverse depreciation in the value of conventional assets | (3.863) | - |
| Charge for depreciation in the value of trade receivables | 52.403 | 35.803 |
| Interest receivable | (965) | (511) |
| Interest payable | 140.667 | 127.813 |
| Taxation | 243.456 | 164.905 |
| Depreciation of deferred income | (4.731) | - |
| Cash from operations before changes in working capital | 1.731.429 | 1.448.777 |
| Decrease in trade and other receivables | 70.867 | 61.864 |
| (Increase)/decrease in conventional assets | (515.389) | 15.826 |
| Increase/(decrease) in trade and other liabilities | 136.910 | (92.174) |
| Cash from operations | 1.423.817 | 1.434.293 |
| Tax paid | (255.995) | (210.581) |
| Net cash from operations | 1.167.822 | 1.223.712 |
| Cash flow from investing activities | ||
| Payments for acquisition of intangible assets | (388.310) | (571.252) |
| Payments for acquisition of property, plant and equipment | (244.918) | (81.723) |
| Proceeds from sale of property, plant and equipment | 6.338 | 8.084 |
| Interest received | 965 | 511 |
| Net cash for investing activities |
(625.925) | (644.380) |
| Cash flow from financing activities | ||
| Repayment of loans | (375.899) | (367.332) |
| Proceeds from new loans | 99.860 | - |
| Interest paid | (140.667) | (127.813) |
| Net cash for financing activities | (416.706) | (495.145) |
| Net increase in cash and cash equivalents |
125.191 | 84.187 |
| Cash and cash equivalents at beginning of year | (1.109.896) | (1.194.083) |
| Cash and cash equivalents at end of year | (984.705) | (1.109.896) |
| Share capital € |
Share premium reserve € |
Revaluation reserve – Land and buildings € |
Foreign currency conversion reserve € |
Annuity reserve € |
Total equity € |
|
|---|---|---|---|---|---|---|
| Balance as at 1 January 2023 | 2.820.547 | 1.282.911 | 1.516.790 | 88.934 | (1.725.921) | 3.983.261 |
| Comprehensive income | ||||||
| Profit for the year | - | - | - | - | 546.009 | 546.009 |
| Other comprehensive income for the year | - | - | 3.945 | (70.547) | - | (66.602) |
| Comprehensive income for the year | - | - | 3.945 | (70.547) | 546.009 | 479.407 |
| Balance as at 31 December 2023 | 2.820.547 | 1.282.911 | 1.520.735 | 18.387 | (1.179.912) | 4.462.668 |
| Share capital € |
Share premium reserve € |
Revaluation reserve – Land and buildings € |
Foreign currency conversion reserve € |
Annuity reserve € |
Total equity € |
|
|---|---|---|---|---|---|---|
| Balance as at 1 January 2024 | 2.820.547 | 1.282.911 | 1.520.735 | 18.387 | (1.179.912) | 4.462.668 |
| Comprehensive income | ||||||
| Profit for the year | - | - | - | - | 764.771 | 764.771 |
| Other comprehensive income | ||||||
| Other comprehensive income for the year | - | - | 3.945 | 3.439 | - | 7.384 |
| Comprehensive income for the year | - | - | 3.945 | 3.439 | 764.771 | 772.155 |
| Transactions with owners | ||||||
| Special contribution for defence in | ||||||
| deemed distribution of dividend and | ||||||
| General Health System (GESY) | - | - | - | - | (21.778) | (21.778) |
| Balance as at 31 December 2024 | 2.820.547 | 1.282.911 | 1.524.680 | 21.826 | (436.919) | 5.213.045 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.